Today, the topic of Ganglionic blocker is of great importance and interest to many people around the world. Whether it is a historical aspect, a relevant personality, a technological advancement or any other topic, Ganglionic blocker has captured the attention of a wide audience. In this article, we will explore in depth different aspects related to Ganglionic blocker, analyzing its impact, relevance and possible implications for the future. From its origins to its current influence, Ganglionic blocker is a topic that leaves no one indifferent and deserves to be carefully examined. Join us on this journey of discovery and inquiry about Ganglionic blocker.
This article needs attention from an expert in pharmacology. See the talk page for details.WikiProject Pharmacology may be able to help recruit an expert.(August 2015)
A ganglionic blocker (or ganglioplegic) is a type of medication that inhibits transmission between preganglionic and postganglionic neurons in the autonomic nervous system, often by acting as a nicotinic receptor antagonist. Nicotinic acetylcholine receptors are found on skeletal muscle, but also within the route of transmission for the parasympathetic and sympathetic nervous system (which together comprise the autonomic nervous system). More specifically, nicotinic receptors are found within the ganglia of the autonomic nervous system, allowing outgoing signals to be transmitted from the presynaptic to the postsynaptic cells. Thus, for example, blocking nicotinic acetylcholine receptors blocks both sympathetic (excitatory) and parasympathetic (calming) stimulation of the heart. The nicotinic antagonist hexamethonium, for example, does this by blocking the transmission of outgoing signals across the autonomic ganglia at the postsynaptic nicotinic acetylcholine receptor.
The opposite of a ganglionic blocker is referred to as a ganglionic stimulant. Some substances can exhibit both stimulating and blocking effects on autonomic ganglia, depending on dosage and/or duration of action. An example for such a "dual" action is nicotine, which does this via depolarization block (see classification below).
Examples
The first ganglion-blocker to be used clinically was tetraethylammonium, although it was soon superseded by better drugs.
Ganglionic blockers are used less frequently now than they were in the past, because antihypertensives with fewer side effects are now available. Hexamethonium has been described as the "first effective antihypertensive drug". However, they are still used in some emergency situations, such as aortic dissection or autonomic dysreflexia.